Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q1 2025
Institutional positions in Evotec SE as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q4 2024
- Shares held
- 9.10M
- +224.1K (+2.5%) vs. Q4 2024
- Total value
- $30.4M
- −$6.53M (−17.7%) vs. Q4 2024
- New holders
- 5
- 5 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 4 | $13 | 0.00% | +4 | New |
| Principal Securities, Inc. | 42 | $175 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 99 | $331 | 0.00% | +5+5.3% | Added |
| Jones Financial Companies LLLP | 150 | $497 | 0.00% | +150 | New |
| Accent Capital Management, LLC | 200 | $668 | 0.00% | −212−51.5% | Reduced |
| US Bancorp | 250 | $835 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 490 | $1.64K | 0.00% | −15−3.0% | Reduced |
| CBIZ Investment Advisory Services, LLC | 840 | $2.81K | 0.00% | 00.0% | Unchanged |
| Briaud Financial Planning, Inc | 2,160 | $7.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 3,052 | $10.2K | 0.00% | −890−22.6% | Reduced |
| Bank of America Corp | 3,888 | $13.0K | 0.00% | −8,940−69.7% | Reduced |
| Quadrant Capital Group LLC | 5,300 | $17.7K | 0.00% | −502−8.7% | Reduced |
| BNP Paribas Arbitrage, SA | 7,400 | $24.7K | 0.00% | +800+12.1% | Added |
| Goldman Sachs Group Inc | 11,868 | $39.6K | 0.00% | −49,250−80.6% | Reduced |
| CSS LLC | 12,100 | $40.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13,620 | $45.5K | 0.00% | +9,914+267.5% | Added |
| Fore Capital, LLC | 17,005 | $56.8K | 0.07% | +17,005 | New |
| Lighthouse Investment Partners, LLC | 37,545 | $125.4K | 0.01% | −2,258−5.7% | Reduced |
| Tower Research Capital LLC (TRC) | 41,185 | $137.6K | 0.00% | +41,185 | New |
| Abc Arbitrage SA | 77,919 | $260.2K | 0.05% | +77,919 | New |
| Morgan Stanley | 88,041 | $294.1K | 0.00% | −37,880−30.1% | Reduced |
| DCF Advisers, LLC | 751,579 | $2.51M | 1.35% | +521,708+227.0% | Added |
| BlackRock, Inc. | 1,522,664 | $5.09M | 0.00% | +78,425+5.4% | Added |
| Wellington Management Group LLP | 1,903,401 | $6.36M | 0.00% | −396,504−17.2% | Reduced |
| Mubadala Investment Co PJSC | 4,597,701 | $15.4M | 0.09% | 00.0% | Unchanged |
| JustInvest LLC | 0 | $0 | 0.00% | −12,836−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −2,543−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −536−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −68−100.0% | Sold out |